AHA Scientific Sessions 2026 Abstract · Nov 2, 2026

Clinical Significance of Blood Pressure and Pulse Pressure in the Perioperative Period of Transcatheter Aortic Valve Implantation

By Sato Y, Yoshihisa A, Okabe A et al.

Background: Transcatheter aortic valve implantation (TAVI) dynamically alters hemodynamic status in patients with severe aortic stenosis. However, perioperative changes in blood pressure and pulse pressure, as well as their prognostic significance, remain unclear. Methods and Results: We analyzed data from 427 patients (mean age, 83.7 years; 34.2% male) with severe aortic stenosis who underwent TAVI (balloon-expandable valve 71.0%, self-expandable valve 29.0%). Morning blood pressure (BP) and pulse pressure were measured at baseline and on postoperative days 1 (POD1) and 2 (POD2), and analyzed in conjunction with laboratory data obtained on the same days. The primary endpoint was all-cause mortality after TAVI. Compared with baseline, BP decreased on POD1, but recovered by POD2 (systolic BP, 130.7, 124.3, and 132.2 mmHg; diastolic BP, 66.0, 49.0, and 65.0 mmHg; P < 0.001 for both). Pulse pressure increased on both POD1 and POD2 compared with baseline (63.0, 74.0, and 66.0 mmHg, respectively; P < 0.001). During a median follow-up period of 719 days after TAVI, 74 patients reached the primary endpoint. When patients were classified into quartiles of systolic BP, diastolic BP, and pulse pressure at each perioperative time point, Kaplan-Meier analysis showed that patients in the lowest quartile of systolic BP and pulse pressure at baseline and POD2 had the lowest survival rates ( Figures 1 , 2 , and 3 ). In multivariable Cox proportional hazards analysis, the lowest quartiles of systolic BP and pulse pressure on POD2, but not at baseline, were associated with increased all-cause mortality after TAVI compared with the highest quartiles, after adjustment for confounders including same-day laboratory data. Conclusion: Low systolic BP and pulse pressure on POD2 were associated with increased mortality after TAVI.

doi.org/10.1161/circ.154.suppl_1.5689Biomarkers

AgingResearch.News